Cargando…
Variability in market uptake of psychotropic medications in Europe reflects cultural diversity
BACKGROUND: In the last 20–30 years, many international studies have found substantial differences in the use of (older) psychotropic medication between European countries. The majority mentioned an important role for attitudes and beliefs towards psychotropic medication. So far, no studies have loo...
Autores principales: | Hoebert, J. M., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., van Dijk, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674841/ https://www.ncbi.nlm.nih.gov/pubmed/29110651 http://dx.doi.org/10.1186/s12913-017-2649-6 |
Ejemplares similares
-
National medicines policies – a review of the evolution and development processes
por: Hoebert, Joëlle M, et al.
Publicado: (2013) -
Linking market authorizations of medicines with disease burden in South Africa
por: Narsai, K., et al.
Publicado: (2021) -
Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements
por: Dankers, Marloes, et al.
Publicado: (2023) -
Post‐marketing dosing changes in the label of biologicals
por: Minnema, Lotte A., et al.
Publicado: (2019) -
Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe
por: Vreman, Rick A., et al.
Publicado: (2020)